US Patent 7897371 Activation of mutated RAC-PK
Patent 7897371 was granted and assigned to Novartis on March, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 5, 2007
0
Date of Patent
March 1, 2011
0
Patent Application Number
11682135
0
Patent Inventor Names
Philip Cohen
0
Darren Cross
0
Mirjana Andjelkovic
0
Peter David Cron
0
Brian A. Hemmings
0
Dario Alessi
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7897371 Activation of mutated RAC-PK
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
